• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers
Get started
Sign in
COVID-19 breakthrough infection rates by co-morbidity during Omicron wave

COVID-19 breakthrough infection rates by co-morbidity during Omicron wave

by Truveta Research | Mar 8, 2022 | Research, Research Insights

Authors: Peter D. Smits, PhD ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl PhD ⊕Truveta, Inc, Bellevue, WA, Michael Simonov, MD ⊕Truveta, Inc, Bellevue, WA Yale School of Medicine, New Haven, CT, Senthil K. Nachimuthu, MD ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin...
Understanding post-Covid-19 infection incidents of heart inflammation in hospitalized patients

Understanding post-Covid-19 infection incidents of heart inflammation in hospitalized patients

by Truveta Research | Feb 24, 2022 | Research, Research Insights

Rates of myocarditis, pericarditis, and other cardiac conditions have been reported both during the acute phase of Covid-19 infection and up to 12-months post infection. Since this is American Heart Month, we wanted to learn more. So, we asked two key questions of a...
COVID-19: Which vaccines are people getting?

COVID-19: Which vaccines are people getting?

by Truveta Research | Feb 3, 2022 | Research, Research Insights

As we shared in our latest Truveta Platform insights last week, the COVID-19 Omicron variant has highlighted the positive impact of vaccinations and boosters in preventing hospitalization. Thus, we wanted to shed light on the percentage of people who are fully...
Percent of COVID-19 hospitalizations decreasing

Percent of COVID-19 hospitalizations decreasing

by Truveta Research | Jan 28, 2022 | Research, Research Insights

Just last week marked the two-year anniversary of the first case of COVID-19 in the United States, discovered by our health system member Providence. It’s hard to believe that it’s been two years, and just this past month we’ve experienced the highest number of daily...
The first insights from the Truveta platform: COVID-19

The first insights from the Truveta platform: COVID-19

by Truveta staff | Nov 9, 2021 | Research, Research Insights

Today is a special day for us at Truveta. In just under two weeks, our team was able to ask and answer an important medical question using one of the largest comprehensive real-time datasets of fully vaccinated Americans. This inaugural custom study is an illustration...
Next Entries »

Share this


Recent posts

  • Real-time monitoring of respiratory virus-associated hospitalizations: Trends through December 2025 
  • Rising use of robotic-assisted surgery in hysterectomy, cholecystectomy, and inguinal hernia repair
  • Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.